期刊文献+

非酒精性脂肪性肝炎相关肝细胞癌特征及诊治进展 被引量:4

Characteristics and diagnosis and treatment progress of nonalcoholic steatohepatitis-related hepatocellular carcinoma
原文传递
导出
摘要 随着非酒精性脂肪性肝病(NAFLD)成为全球第一大慢性肝病后,非酒精性脂肪性肝炎相关肝癌(NASH-HCC)患者逐年增加,并渐成为肝癌最普遍病因。与其他病因肝癌明显不同,NASH-HCC与遗传因素、代谢综合征、肠道菌群改变和持续炎症等危险因素有关,临床上NASH-HCC多发生于年龄较大、男性、肥胖患者,并可由无肝硬化的NAFLD发展而来,在超声、CT及MRI检查中各有其相对特征性的表现。本文就NASH-HCC特征及诊治进展进行综述。 Considering that nonalcoholic fatty liver disease(NAFLD)has become the world′s first chronic liver disease,patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma(NASH-HCC)have increased dramatically,and it has leapt to the most common cause of liver cancer.Unlike other causes of liver cancer,NASH-HCC is strongly associated with the cluster of risk factors including genetic factors,metabolic syndrome,gut microbiota and chronic persistent inflammation.Clinically,NASH-HCC mostly occurs in aging,male,obese patients,and can evolve from NAFLD without cirrhosis.The relatively characteristic manifestations of NASH-HCC in ultrasound,CT and MRI examinations are significantly different from other causes of liver cancer.This article reviews the characteristics and the progress of NASH-HCC in diagnosis and treatment.
作者 陈利 朱风尚 杨长青 Chen Li;Zhu Fengshang;Yang Changqing(Department of Gastroenterology,Tongji Hospital of Tongji University,Shanghai 200065,China)
出处 《中华消化病与影像杂志(电子版)》 2020年第6期267-271,共5页 Chinese Journal of Digestion and Medical Imageology(Electronic Edition)
基金 上海市临床重点专科建设项目基金(shslczdzk06801)。
关键词 非酒精性脂肪性肝病 肝细胞癌 非酒精性脂肪性肝炎相关肝细胞癌 Nonalcoholic fatty liver disease Hepatocellular carcinoma Nonalcoholic steatohepatitis-related hepatocellular carcinoma
  • 相关文献

参考文献3

二级参考文献36

  • 1Elisabetta B, Nicola L, EsterV, et al. Expanding the natural history of nonalcoholic steatoheptitis: From cryptogenic cirrhosis to hepatocellular careinoma [ J]. Gastroenterology, 2003, 123 ( 1 ) : 134 - 143.
  • 2Hashimoto E, Taniai M, Kaneda H, et al. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis [ J ]. Alcohol Clin Exp Res, 2004, 28 (Suppl 8): 164S - 168S.
  • 3Yoshioka Y, Hashimoto E, Yatsuji S, et al. Nonalcoholicsteatohepatitis : cirrhosis, hepatoceUular carcinoma, and burnt - out NASH[J]. Gastroenterol, 2004, 39(12) : 1215 - 1218.
  • 4Caldwell SH, Crespo DM, Kang HS, et al. Obesity and hepatocellular carcinoma [ J ]. Gastroenterology, 2004, 127 (5 Suppl 1 ) :S97 - 103.
  • 5Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis :from cryptogenic cirrhosis to hepatocellular carcinoma[ J ]. Gastroenterology, 2002, 123 ( 1 ) : 134 - 140.
  • 6Nair S, Mason A, Eason J. Is obesity an independent risk factor for hepatoeellular carcinoma in cirrhosis [ J ]. Hepatology, 2002, 36 (1): 150 - 155.
  • 7Ipekci SH, Basaranoglu M, Sonsuz A. The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis [J]. J Clin Gastroenterol, 2003, 36(4):371.
  • 8Hoofnagle JH, Van Natta ML, Kleiner DE, et al. Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis [ J ]. Aliment Pharmacol Ther, 2013, 38(2): 134-143.
  • 9Festi D, Schiumerini R, Marzi L, et al. Review article: the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods [ J ]. Aliment Pharmacol Ther, 2013, 37(4): 392-400.
  • 10Feldstein AE, Wieckowska A, Lopez AR, et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a muhicenter validation study [J]. Hepatology, 2009, 50(4): 1072-1078.

共引文献4

同被引文献37

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部